Results 161 to 170 of about 17,590 (203)

Illegitimate V(D)J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma

Blood, 2012
Abstract Abstract 1323 V(D)J recombination of antigen receptor loci confers diversity to the mammalian immune system. However, off-target, illegitimate V(D)J recombination between non-antigen receptor loci, leading to site-specific interstitial deletion has been reported in humans and mice with lymphoid malignancies. These
Hyunkyung Kim, Ying-Wei Lin, Yongzhi Cui, Sheryl M. Gough, Peter D. Aplan, Crystal L. Mackall, Sarah H. Beachy, Masahiro Onozawa   +7 more
openaire   +2 more sources

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Blood, 2014
Abstract Introduction: Recently, early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) was identified as a subtype of T-cell ALL (T-ALL), with distinctive gene expression and cell marker profiles. Some reports revealed that ETP-ALL was associated with a high risk of remission induction failure and relapse.
Reiji Fukano, Masahito Tsurusawa, Akiko Saito, Tetsuo Mitsui, Masahiro Sekimizu, Keizo Horibe, Tetsuya Takimoto, Ryoji Kobayashi, Tomoyuki Watanabe, Tetsuya Mori, Nobutaka Kiyokawa, Junichiro Fujimoto, Shosuke Sunami, Koichi Ohshima, Takeshi Mori, Atsuko Nakazawa   +15 more
openaire   +2 more sources

Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Journal of Pediatric Hematology/Oncology, 2018
We reviewed the immunophenotypic subtypes of pediatric T-cell lymphoblastic lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 study. Of the 104 patients, 40 patients each had sufficient data to evaluate the immunophenotypes and early T-cell precursor (ETP) subtype.
Tetsuo Mitsui, Tetsuya Takimoto, Keizo Horibe, Koichi Ohshima, Akiko Saito, Atsuko Nakazawa, Masahiro Sekimizu, Masahito Tsurusawa, Tomoyuki Watanabe, Tetsuya Mori, Ryoji Kobayashi, Junichiro Fujimoto, Reiji Fukano, Takeshi Mori, Nobutaka Kiyokawa, Shosuke Sunami   +15 more
openaire   +3 more sources

Human medicines European public assessment report (EPAR): Sprycel, dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Date of authorisation: 20/11/2006, Revision: 32, Status: Authorised

Case Medical Research, 2019

  +4 more sources

[Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma from Multicenter].

Zhongguo shi yan xue ye xue za zhi
To analyze the clinical characteristics, treatment, and prognosis of adult patients with early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL).Clinical data of 113 T lymphoblastic leukemia/lymphoma (T-ALL/LBL) patients from January 2006 to January 2019 were collected from three hematology research centers, including Peking ...
Zheng-Hua Li, Lan Luo, Ping Yang, Yan Li, Dehui Zou, Chunji Gao, Hongmei Jing   +6 more
openalex   +3 more sources

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 28/06/2017, Revision: 3, Status: Authorised

Case Medical Research, 2018

openalex   +2 more sources

Solvent Engineering of the Precursor Solution toward Large‐Area Production of Perovskite Solar Cells

Advanced Materials, 2021
Lin Song, Lingfeng Chao, Tingting Niu
exaly  

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

Ca-A Cancer Journal for Clinicians, 2016
Peter A S Johnstone, Anna R Giuliano
exaly  

A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control

Ca-A Cancer Journal for Clinicians, 2019
Otis W Brawley, Ted Gansler, Robert A Smith   +2 more
exaly